E L Bravo - Concepedia

Author

E L Bravo

Also Known As

D. G. Vidt, E BRAVO, E L Bravo, E. Bravo, E. L Bravo, E. L. Bravo, E.L. BRAVO, E.L. Bravo, EMANNUEL L. BRAVO, Edina Bravo

Publications

961

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Institución Universitaria Pascual Bravo Hypertension Institute Textron Systems (United Kingdom)Cleveland Foundation

About

E L Bravo is an author at Cleveland Clinic specializing in medicine, hypertension, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	477
2	Health Sciences	5	5	158
3	Endocrinology	4	4	167
4	Nephrology	4	4	165
5	Metabolism	1	1	24

E L Bravo

Publications

644

Citations

H-Index

Page 1

	Year	Citations
Hemodynamic and volume changes associated with captopril. Robert C. Tarazi, E L Bravo, F. M. Fouad, Hypertension	1980	96
Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure. Salim Mujais, F. M. Fouad, Stephen C. Textor, Heart HypertensionHeart FailureRenal Plasma FlowBlood PressureRenal Function	1984	64
Blood pressure regulation in pheochromocytoma. E L Bravo, Robert C. Tarazi, F. M. Fouad, Hypertension HypertensionBlood PressureThrombosisAdrenal GlandSympathetic Nervous System	1982	61
Hypokalemia, in Bartter's Syndrome and Other Disorders, Produces Resistance to Vasopressors via Prostaglandin Overproduction Navid Radfar, J R Gill, Frederic C. Bartter, Experimental Biology and Medicine HypertensionElectrolyte DisorderProstaglandin SynthesisBlood PressureProstaglandin Overproduction	1978	45
FINANCIAL ANALYSIS OF NEEDLESCOPIC VERSUS OPEN ADRENALECTOMY MICHAEL G. HOBART, Inderbir S. Gill, Dana Schweizer, The Journal of Urology	1999	37
The sympathetic nervous system and hypertension in primary aldosteronism. E L Bravo, Robert C. Tarazi, H P Dustan, Hypertension HypertensionAdrenal GlandCardiovascular DiseaseMedicineSympathetic Nervous System	1985	37
Differences in Left Ventricular Structural and Functional Changes Between Pheochromocytoma and Essential Hypertension: Role of Elevated Circulating Catecholamines Fetnat M. Fouad-Tarazi, Masakazu Imamura, E L Bravo, American Journal of Hypertension HypertensionHeart FailureCardiovascular FunctionExperimental FindingsDiastolic Function	1992	35
Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril). F. M. Fouad, Robert C. Tarazi, E L Bravo, Hypertension HypertensionMm Hg PretreatmentCardiovascular PharmacologyPretreatment PeriodPharmacotherapy	1984	32
Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma E L Bravo Endocrine Reviews Adrenal GlandCesar RouxEndocrine DiseaseMedicineHematology	1994	32
Haemodynamic effects of propranolol in hypertension: a review. Robert C. Tarazi, H P Dustan, E L Bravo PubMed HypertensionHeart FailureBlood PressureDiastolic FunctionCardiology	1976	30

Page 1